GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Ajanta Pharma AJANTPHARM.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

3,344.00

+1.10%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹54.53bn

FY2017FY2026

Net income

₹10.56bn

FY2017FY2026

Free cash flow

₹1.51bn

FY2017FY2026

Shareholders' equity

₹45.27bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹54.53bn₹45.88bn₹41.62bn₹37.08bn₹32.84bn₹28.45bn₹25.62bn₹20.16bn₹20.60bn₹19.16bn
Research and development—₹2.24bn₹2.08bn₹2.37bn₹2.04bn₹1.39bn₹1.64bn₹1.76bn₹1.86bn₹1.50bn
Operating income₹13.94bn₹12.10bn₹11.21bn₹7.51bn₹9.20bn₹9.08bn₹6.76bn₹5.03bn₹6.07bn₹6.65bn
Net income₹10.56bn₹9.20bn₹8.16bn₹5.88bn₹7.13bn₹6.54bn₹4.68bn₹3.87bn₹4.69bn₹5.07bn
Diluted earnings per share84.4273.6765.1546.6755.6250.3636.0329.5535.4938.40

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹61.55bn₹50.15bn₹46.38bn₹46.79bn₹40.56bn₹37.79bn₹33.19bn₹26.96bn₹24.49bn₹18.23bn
Cash and short-term investments₹6.65bn₹6.15bn₹4.60bn₹8.44bn₹3.28bn₹3.78bn₹2.69bn₹1.60bn₹2.75bn₹2.33bn
Total liabilities₹16.28bn₹12.25bn₹10.71bn₹12.91bn₹7.91bn₹7.83bn₹7.20bn₹4.51bn₹4.07bn₹2.55bn
Debt₹2.60bn₹474.2m₹352.8m₹356.3m₹250.3m₹313.6m₹749.6m₹359.6m₹18.0m₹68.1m
Shareholders' equity₹45.27bn₹37.90bn₹35.67bn₹33.88bn₹32.64bn₹29.96bn₹25.99bn₹22.45bn₹20.41bn₹15.68bn
Shares outstanding125m125m125m126m128m130m130m131m132m132m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹5.16bn₹11.57bn₹7.85bn₹7.92bn₹5.62bn₹5.76bn₹4.57bn₹3.75bn₹2.85bn₹6.08bn
Capital spending−₹3.65bn−₹3.18bn−₹1.52bn−₹1.74bn−₹1.49bn−₹1.72bn−₹2.39bn−₹3.43bn−₹2.63bn−₹3.01bn
Free cash flow₹1.51bn₹8.39bn₹6.33bn₹6.17bn₹4.13bn₹4.05bn₹2.17bn₹318.1m₹227.0m₹3.07bn
Dividends paid−₹3.50bn−₹3.49bn−₹6.42bn−₹896.9m−₹822.1m−₹829.0m−₹1.13bn−₹791.2m−₹3.0m−₹1.14bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹16.26bn₹14.22bn₹13.75bn₹13.54bn₹13.03bn₹11.10bn₹11.46bn₹11.87bn
Operating income₹4.10bn₹7.31bn₹7.15bn₹3.26bn₹6.83bn₹2.84bn₹5.87bn₹6.30bn
Net income₹3.34bn₹2.67bn₹2.74bn₹2.60bn₹2.55bn₹2.25bn₹2.33bn₹2.16bn
Diluted earnings per share26.7221.3221.9120.8320.4418.0318.5917.28
Cash from operations———₹2.84bn—₹11.57bn—₹7.76bn
Capital spending———−₹1.73bn—−₹3.18bn—−₹1.50bn
Free cash flow———₹1.10bn—₹8.39bn—₹6.27bn
Total assets—₹61.55bn—₹56.72bn—₹50.15bn—₹47.91bn
Cash and short-term investments₹6.65bn₹6.65bn₹9.40bn₹9.40bn₹6.14bn₹6.15bn₹7.42bn₹7.42bn
Debt—₹2.21bn—₹2.46bn—₹474.2m—₹327.9m
Shareholders' equity₹45.27bn₹45.27bn₹43.15bn₹43.15bn₹37.90bn₹37.90bn₹36.77bn₹36.77bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.7%13.9%12.3%
Operating income22.9%8.9%9.7%
Net income21.6%10.1%9.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin25.9%25.0%26.2%27.1%
Net margin19.7%18.9%19.7%20.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings39.437.645.044.621.829.630.222.022.225.9
Price to sales7.67.58.87.14.76.85.54.25.06.9

Dividends and splits

Per share, in the currency the company pays

Paid for 20 years. Last went ex-dividend on 5 Aug 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year32.0028.0028.0051.007.006.3336.3338.667
  • 3-for-2 split · 22 Jun 2022
  • 5-for-2 split · 20 Mar 2015
  • 3-for-2 split · 17 Sept 2013
  • 2-for-1 split · 9 Aug 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.